e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Neuroendocrine tumours of the lung other than SCLC
A.M. Dingemans(Rotterdam, Netherlands), J. Derks (Maastricht, Netherlands)
Source:
ERS webinar 2021: Neuroendocrine tumours of the lung other than SCLC
Number:
0
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A.M. Dingemans(Rotterdam, Netherlands), J. Derks (Maastricht, Netherlands). Neuroendocrine tumours of the lung other than SCLC. ERS webinar 2021: Neuroendocrine tumours of the lung other than SCLC
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Carcionoid tumors of the lung
Source: Eur Respir J 2002; 20: Suppl. 38, 457s
Year: 2002
Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006
Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation
Source: Eur Respir J 2002; 20: Suppl. 38, 270s
Year: 2002
Neuroendocrine lung carcinoma in a child
Source: Annual Congress 2009 - Various diagnostic aspects in lung cancer and rare lung tumours
Year: 2009
Neuroendocrine carcinoma of the lung in a child
Source: Eur Respir J 2005; 26: Suppl. 49, 537s
Year: 2005
Synchronous primary lung cancer with three separate tumors
Source: Annual Congress 2007 - Lung neoplasms
Year: 2007
The impact of neuroendocrine differentiation in the prognosis of non-small cell lung cancer
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Should there be a specific management for large cell neuroendocrine carcinoma?
Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Year: 2005
Lung cancer
Source: Respipedia Article
Year: 2018
How to treat a T1-T3N0 non-small cell lung cancer (NSCLC) with isolated brain metastasis
Source: International Congress 2015 – How to treat brain metastases
Year: 2015
Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Other neuroendocrine tumors
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Venothromboembolism in lung cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 601s
Year: 2007
Staging of lung cancer
Source: Eur Respir Mon; 2009: 44: 150–168
Year: 2009
Aerosoltherapy in lung cancer
Source: Annual Congress 2008 - Therapy in thoracic oncology
Year: 2008
Multiple carcinomas in the lung cancer patients
Source: Eur Respir J 2007; 30: Suppl. 51, 671s
Year: 2007
A rare involvement in a male patient with non-small cell lung carcinoma: breast metastasis
Source: Eur Respir J 2005; 26: Suppl. 49, 538s
Year: 2005
How to treat brain metastasis in patients with non-small cell lung carcinoma (NSCLC) and EGFR mutations
Source: International Congress 2015 – How to treat brain metastases
Year: 2015
Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Detecting extrathoracic metastases in patients with non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 41s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept